Weishi

This study tests a personalized approach to prevent cytomegalovirus (CMV) infection in adults who have received a stem cell transplant. Instead of giving the anti-CMV drug letermovir for a fixed 100 days, researchers will use a blood test to check when each patient's immune syste…